Brent Bluett, DO, Stanford Movement Disorder Specialist, will discuss “The Latest Parkinson’s Research: Is There Hope?” at the Palo Alto Support group on Wednesday, January 8, from 2:30-4:00pm, at Channing House in Palo  Alto. No RSVP is required to attend.

Here are the meeting details:

Where: 
Channing House, 850 Webster St., Palo Alto 94301. Parking, including disabled parking, may be available in the parking lot in front of the building. Passengers may be dropped off at the front entrance. Additional free parking (for up to two hours) is available on adjacent streets, including Channing (one-way, eastbound), Homer (one-way, westbound). Valet parking is also available.  

When: 
Wednesday, January 8, 2:30-4:00pm 

About the group: 
The Palo Alto Support Group provides educational materials and engaging, knowledgeable speakers for anyone wanting to learn more about Parkinson’s. 

We maintain a reminder email list-you may join any of our lists  online or sign up for one or more of our lists at the meeting. The meeting is free and open to the public. No RSVP is required to attend. 

About the speaker: 
Brent Bluett, DO, is a movement disorders specialist at  Stanford’s Movement Disorders Center. Dr. Bluett received his bachelor’s degree in psychology at the University of California at Santa Barbara.  He graduated medical school at Touro University with national osteopathic medicine honors as a member of Sigma Signa Phi.  He completed neurology residency at the University of Texas Southwestern at Austin, during which he was resident chair of the Texas Neurological Society. Afterwards, he went on to obtain a fellowship in Movement Disorders at the University of California San Diego directed by Dr. Irene Litvan, a world renowned expert in atypical parkinsonism. Prior to joining the Stanford movement disorders program, Dr. Bluett worked at the Cleveland Clinic Lou Ruvo Center for Brain Health. 

Dr. Bluett’s clinical expertise is in all movement disorders including Parkinson’s disease, essential tremor, Huntington’s disease, dystonia, normal pressure hydrocephalus, ataxia, and atypical parkinsonism (progressive supranuclear Palsy, dementia with lewy bodies, corticobasal degeneration, and multiple system atrophy). He is trained and skilled in the administration of botulinum toxin injections and deep brain stimulation programming.

Dr. Bluett is a member of the Parkinson Study Group, Huntington Study Group, National Ataxia Foundation, Dystonia Medical Research Foundation, and he recently helped create and develop the CurePSP Centers of Care – a national initiative dedicated to increasing access to care and advancing research initiatives for progressive supranuclear palsy and corticobasal degeneration. 

Dr. Bluett’s research focuses on falls prevention in movement disorders. He received NIH grant funding to explore freezing of gait in Parkinson’s disease, in order to better understand the underlying pathophysiology. He is expanding this research at Stanford University by using virtual reality to explore treatments for this disabling phenomenon. 

We often feature research updates in our informational emails or on our blog. Sign up for our mailing lists online or at the meeting (see above). We also feature links to regional and national organizations that highlight  current research. Visit our resources page.